Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 38
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02600494 | Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression | ||
| NCT03249376 | Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally | ||
| NCT05850689 | Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | ||
| NCT05732194 | Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers | ||
| NCT06651567 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia | ||
| NCT05470101 | A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects | ||
| NCT01499563 | Study of a Novel Antipsychotic ITI-007 in Schizophrenia | ||
| NCT06462612 | Study of Lumateperone in the Treatment of Patients With Bipolar Mania | ||
| NCT03257046 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease | ||
| NCT03489772 | Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement | ||
| NCT02078310 | Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia | ||
| NCT06299410 | PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects | ||
| NCT04709224 | Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia | ||
| NCT04934124 | Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers | ||
| NCT05061719 | An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | ||
| NCT06174116 | Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia | ||
| NCT06229210 | Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder | ||
| NCT06462586 | Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania | ||
| NCT02469155 | A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment | ||
| NCT06627413 | Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder | ||
| NCT05061706 | Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | ||
| NCT05766813 | Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease | ||
| NCT02817906 | ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease | ||
| NCT05356013 | Caplyta in Borderline Personality Disorder | ||
| NCT06372964 | Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients | ||
| NCT06557902 | Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder | ||
| NCT03387215 | Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure | ||
| NCT02600507 | Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression | ||
| NCT04959032 | Lumateperone for the Prevention of Relapse in Patients With Schizophrenia | ||
| NCT04285515 | Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder | ||
| NCT02282761 | A Trial to Assess the Antipsychotic Efficacy of ITI-007 | ||
| NCT03817528 | ITI-007 (Lumateperone Tosylate) for Schizophrenia | ||
| NCT06480383 | Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder | ||
| NCT02288845 | Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia | ||
| NCT01900522 | Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia | ||
| NCT04985942 | Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | ||
| NCT04779177 | Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder | ||
| NCT06540833 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease |
